Publications
CM Gabbott, E Mele, T Sun. Cell marbles: A novel cell encapsulation technology by wrapping cell suspension droplets using electrospun nanofibers for developmental engineering. July 2020 Journal of Biotechnology 323 DOI: 10.1016/j.jbiotec.2020.07.020
CM Gabbott, T Sun. A scale down design for mechanistic understanding of cell-scaffold interactions. May 2018 Cytotherapy 20(5):S85 DOI: 10.1016/j.jcyt.2018.02.240
CM Gabbott, T Sun. Comparison of Human Dermal Fibroblasts and HaCat Cells Cultured in Medium with or without Serum via a Generic Tissue Engineering Research Platform. January 2018 International Journal of Molecular Sciences 19(2) DOI: 10.3390/ijms19020388
CM Gabbott, T Sun. Mechanistic Insights of Cells in Porous Scaffolds via Integrated Culture Technologies. December 2017 Journal of Life Sciences doi: 10.17265/1934-7391/2017.04.001
CM Gabbott. Z X Houg, X Han, T Sun. A novel scale-down cell culture and imaging design for the mechanistic insight of cell colonisation within porous substrate. March 2017 Journal of Microscopy 267(2) DOI: 10.1111/jmi.12555
Areas of Expertise
- Phase II-III Clinical Trials
- Investigational Medicinal Products
- Medical Devices
- Good Clinical Practice
- Cell and Gene Therapy
- Haematology
- Tissue Engineering
- Bid and Grant Writing
Roles and Responsibilities
Dr Chris Gabbott is a biological and genomic scientist at MTIF who engages with a diverse clientele in medical tech. He uses various techniques essential to cell therapy development, blood analysis, imaging, and genomics.
Dr Gabbott has a background in regenerative medicine and has previously worked in the pharmaceutical and clinical trials industry. Transitioning from there, he undertook a role as a Research Fellow at NTU, focusing on Tissue Engineering before moving to MTIF.
